BlueCrest Capital Management’s Exelixis EXEL Stock Holding History

BlueCrest Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-61,371	Closed	-$1.36M	–	1574
2018 Q1	$1.36M	Buy	+61,371	New	+$1.7M	0.04%	405
2017 Q3	–	Sell	-222,241	Closed	-$5.47M	–	919
2017 Q2	$5.47M	Buy	+222,241	New	+$4.7M	0.21%	148
2016 Q1	–	Sell	-68,109	Closed	-$384K	–	874
2015 Q4	$384K	Buy	+68,109	New	+$381K	0.02%	659

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlueCrest Capital Management's EXEL Position: Q2 2018 in Review

BlueCrest Capital Management sold out of Exelixis (EXEL) in Q2 2018, closing a stake of 61,371 shares — an estimated $1.36M sold.

BlueCrest Capital Management first reported a position in EXEL in Q4 2015 and held it in 3 quarters. The position peaked at $5.47M in Q2 2017. 303 funds tracked by Wall St. Rank hold EXEL as of Q2 2018.

BlueCrest Capital Management reported no remaining Exelixis position as of Q2 2018 after selling out during the quarter.
BlueCrest Capital Management sold 61,371 Exelixis shares in Q2 2018, an estimated $1.36M.
BlueCrest Capital Management first reported a position in Exelixis in Q4 2015 and held it in 3 quarters.
BlueCrest Capital Management's Exelixis position peaked at $5.47M in Q2 2017.
303 funds tracked by Wall St. Rank held Exelixis as of Q2 2018.

Based on BlueCrest Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.